Udvalget konkluderede imidlertid, at Cyanokit havde fordele frem for alternative modgifte, fordi det har en god sikkerhedsprofil hos patienter, der ikke er forgiftet.
However, the Committee concluded that Cyanokit had advantages over alternative antidotes because it has a good safety profile in patients who have not been poisoned.